Skip to main content

Find Clinical Trials

Home
Conditions
Multiple Sclerosis

Clinical trial condition

Multiple Sclerosis

Explore clinical trials studying Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

2,414 public trials 350 recruiting studies

Refine in advanced search Browse all conditions

Multiple Sclerosis trial results

Completed

Study to Determine if Avonex and Rebif Work Comparably Well in Subjects With Relapsing Multiple Sclerosis

NCT00599274

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Research Site Los Angeles, California, United States

Research Site Walnut Creek, California, United States

Research Site Shreveport, Louisiana, United States

Research Site Worcester, Massachusetts, United States

View Trial Details

Completed

Levetiracetam in Central Pain in Multiple Sclerosis(MS)

NCT00423527

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Department of Neurology, Odense University Hospital Odense C, Denmark

View Trial Details

Completed

FOCUS Fatigue Outcome in Copaxone USers

NCT00267319

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Sanofi-Aventis Prague, Czechia

View Trial Details

Completed

Exploratory Study to Investigate the Reparative and Regenerative Potential of Alemtuzumab in Relapsing-Remitting Multiple Sclerosis Patients Participating in the CARE MS I and MS II Studies

NCT01020370

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Not specified

View Trial Details

Completed

BEYOND Pilot Study

NCT00893217

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations: Los Angeles, California, United States

Washington D.C., District of Columbia, United States

Atlanta, Georgia, United States

Chicago, Illinois, United States

View all 14 locations

View Trial Details

Completed

A Multicenter Study to Assess the Effect of Plasma Exchange in Accelerating the Clearance of Natalizumab in Subjects With Multiple Sclerosis (MS)

NCT00424788

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations: Cleveland Clinic Mellen Center for MS Cleveland, Ohio, United States

Center for Neurological Disorders, Aurora Health Care Milwaukee, Wisconsin, United States

View Trial Details

Completed

Atorvastatin 40 mg in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Interferon-Beta-1b

NCT00942591

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Prof. H. Mattle, Dep. of Neurology, Bern University Hospital Bern, Switzerland

View Trial Details

Completed

EARLY IFNb-1a and Atorvastatin Combination Therapy of Isolated Clinical Syndrome Suggestive of Multiple Sclerosis

NCT00137176

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: University of North Carolina-Chapel Hill MS Clinic Within the Neuroscience Hospital Chapel Hill, North Carolina, United States

View Trial Details

Completed

Open-Label Natalizumab Safety Extension Study

NCT00276172

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Performed at only C-1801, C-1802, and C-1803 sites globally. No general public enrollment. Biogen Idec is located in Cambridge, Massachusetts, United States

View Trial Details

Completed

Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis

NCT00030966

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations: University of Alabama-Birmingham, Department of Neurology Birmingham, Alabama, United States

Phoenix Neurological Associates, Ltd. Phoenix, Arizona, United States

University of Arkansas For Medical Sciences Little Rock, Arkansas, United States

University of California - Irvine Irvine, California, United States

View all 88 locations

View Trial Details